Melissa Zipprich
Medical · Hardin, ILNPI 1457518847
Payments from drug & device makers
Across 125 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$482
- Novo Nordisk$413
- Johnson & Johnson$231
- Lilly USA, LLC$222
- AbbVie$212
- Boehringer Ingelheim$100
- plus $476 from 11 others
What the payments were for
- Food & beverage$2,134100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 27 | $482 |
| Novo Nordisk | 23 | $413 |
| Johnson & Johnson | 18 | $231 |
| Lilly USA, LLC | 11 | $222 |
| AbbVie | 14 | $212 |
| Boehringer Ingelheim | 6 | $100 |
| Lundbeck LLC | 4 | $81 |
| Novartis | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Bayer | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Philips North America LLC | 2 | $40 |
| AstraZeneca | 2 | $33 |
| Exact Sciences | 2 | $30 |
| Merck | 2 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $15 |
How this compares
$2,134 in reported general payments places this provider in the 75th percentile of 449 medical providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $73,650 |
| JardianceEmpagliflozin | 63 | $59,226 |
| EliquisApixaban | 54 | $46,288 |
| TradjentaLinagliptin | 58 | $44,696 |
| JanuviaSitagliptin Phosphate | 36 | $37,533 |
| TrulicityDulaglutide | 12 | $22,609 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $6,418 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $5,205 |
| Novolog FlexpenInsulin Aspart | 13 | $3,136 |
| Duloxetine Hcl | 67 | $1,762 |
| Levothyroxine Sodium | 220 | $1,761 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 54 | $1,727 |
| Ventolin HfaAlbuterol Sulfate | 18 | $1,675 |
| Rosuvastatin Calcium | 171 | $1,539 |
| Atorvastatin Calcium | 177 | $1,534 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $100 | $103,921121 claims |
| Novo NordiskOzempic | $413 | $73,65069 claims |
| MerckJanuvia | $26 | $37,53336 claims |
| Lilly USA, LLCTrulicity | $222 | $22,60912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 449 medical providers in Illinois.
Other medical in Hardin
- Andrea TurekChicago$145K
- Priya BediElmhurst$56K
- Jennifer GarsonChicago$32K
- Bernice JohnsonPalos Heights$32K
- William KvasnickaChicago$19K
- Katie SpringerLake Forest$17K
- Matthew BrunoMorris$17K
- Kelly BrawleyBarrington$14K
- Megan GriggsSpringfield$13K
- Marianne RaoAlgonquin$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.